文献速递脑血管病

他汀类药物使用与自发性脑出血的关联:一项队列研究

Association of statin use with spontaneous intracerebral hemorrhage: A cohort study.
PubMed 文献 · Neurology · 2018-07-03

基于以色列最大医疗服务机构数据库,纳入2005至2010年间新开始他汀治疗的患者345,531例,中位随访9.5年,按平均阿托伐他汀等效日剂量(AAEDD)分析他汀暴露与脑出血(ICH)的剂量依赖关联,结果显示AAEDD较高者ICH风险较低,且胆固醇水平越高ICH风险越低。

要点

  • 中位随访9.5年,345,531例新使用他汀者中1,304例诊断为脑出血。
  • 与AAEDD<10 mg/d相比,AAEDD 10-19.9 mg/d者ICH的调整HR为0.68(95%CI 0.58-0.79),AAEDD≥20 mg/d者为0.62(95%CI 0.47-0.81)。
  • 与最低基线总胆固醇四分位相比,第二、第三、最高四分位的ICH调整HR分别为0.71、0.55、0.57。

核心结论

  • 本研究证实胆固醇水平越高脑出血风险越低,但提示他汀使用可能与脑出血风险降低相关。

研究设计与样本

  • 基于以色列最大医疗服务机构的计算机数据库,识别2005至2010年间新开始他汀治疗并诊断为脑出血的患者,纳入345,531例,中位随访9.5年(四分位距7.6-11.0)。
  • 采用平均阿托伐他汀等效日剂量(AAEDD)评估他汀与脑出血的剂量反应关系,应用多变量Cox比例风险回归模型并调整基线疾病风险评分以估计脑出血的风险比。

主要发现

  • 纳入的345,531例患者中,1,304例在中位随访9.5年(四分位距7.6-11.0)期间诊断为脑出血。
  • 总体中AAEDD<10 mg/d者占75.3%,AAEDD 0-19.9 mg/d者占19.0%,AAEDD≥20 mg/d者占5.7%;脑出血病例中对应比例分别为81.0%、15.0%、4.0%,非脑出血病例中分别为75.3%、19.0%、5.7%。
  • 与AAEDD<10 mg/d(参照组)相比,AAEDD 10-19.9 mg/d者脑出血的调整HR为0.68(95%CI 0.58-0.79),AAEDD≥20 mg/d者为0.62(95%CI 0.47-0.81)。
  • 与最低基线总胆固醇四分位相比,第二、第三、最高四分位的脑出血调整HR分别为0.71(95%CI 0.62-0.82)、0.55(95%CI 0.47-0.64)、0.57(95%CI 0.49-0.67)。
  • 在高度坚持他汀治疗者中以及控制胆固醇水平变化后,结果相似且稳健。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the association between statin exposure in a dose-dependent manner and intracerebral hemorrhage (ICH) in a large nationwide study. METHODS: The computerized database of the largest health care provider in Israel was used to identify diagnosed ICH among new users of statins, who started statin treatment between 2005 and 2010. We assessed a dose-response relationship between ICH and statins, using the average atorvastatin equivalent daily dose (AAEDD). Multivariable Cox proportional hazard regression models, adjusted for baseline disease risk score, were applied to estimate the hazard ratio of ICH. RESULTS: Of the 345,531 included patients, 1,304 were diagnosed with ICH during a median follow-up of 9.5 years (interquartile range 7.6-11.0). Overall, 75.3% of patients had AAEDD <10 mg/d, 19.0% had AAEDD 0-19.9 mg/d, and 5.7% had AAEDD ≥20 mg/d. The corresponding proportions were 81.0%, 15.0%, 4.0% among ICH cases, and 75.3%, 19.0%, 5.7% among non-ICH cases. Compared to those with AAEDD <10 mg/d (reference), the adjusted hazard ratio (HR) for ICH was 0.68 (95% confidence interval [CI] 0.58-0.79) in those with AAEDD 10-19.9 mg/d, and 0.62 (0.47-0.81) in those with AAEDD ≥20 mg/d. Compared to the lowest baseline total cholesterol quartile, the adjusted HR for ICH was 0.71 (95% CI 0.62-0.82), 0.55 (0.47-0.64), and 0.57 (0.49-0.67) in those in the second, third, and highest quartiles, respectively. The results were similar and robust among highly persistent statin users and after controlling for the change in cholesterol level. CONCLUSIONS: This study confirms that the risk of ICH decreases with increasing cholesterol levels, but suggests that statin use might be associated with decreased risk of ICH.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Saliba W, Rennert HS, Barnett-Griness O, et al. Association of statin use with spontaneous intracerebral hemorrhage: A cohort study. Neurology. 2018. PMID: 29970405. doi:10.1212/WNL.0000000000005907

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。